EUCTR2004-001540-71-ITActive, not recruitingNot Applicable
Randomized, Double Bilnd, Controlled, Parallel-Group, Multicenter Study of a Subcutaneous Formulation of Icatbant vs. oral Tranexamic Acid for the Treatment of Hereditary Angioedema (HAE)
Drugs
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Sponsor
- JERINI AG
- Enrollment
- 74
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Active, not recruiting
Phase 1
Effects of Depth of Neuromuscular Blockade and Insufflation Pressure on Surgical ConditionsEUCTR2012-001886-33-GBMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.127
Active, not recruiting
Not Applicable
Effects of Depth of Neuromuscular Blockade and Insufflation Pressure on Surgical ConditionsPatients undergoing elective in-patient laparoscopic cholecystectomy procedures under general anesthesia with neuromuscular relaxation and active reversal of neuromuscular blockadeMedDRA version: 14.1Level: LLTClassification code 10018061Term: General anesthesiaSystem Organ Class: 100000004865EUCTR2012-001886-33-FIMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.120
Active, not recruiting
Phase 1
Effects of Depth of Neuromuscular Blockade and Insufflation Pressure on Surgical Conditions.Patients undergoing elective in-patient laparoscopic cholecystectomy procedures under general anesthesia with neuromuscular relaxation and active reversal of neuromuscular blockade.MedDRA version: 14.1 Level: LLT Classification code 10018061 Term: General anesthesia System Organ Class: 100000004865EUCTR2012-001886-33-ITMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.127
Active, not recruiting
Not Applicable
Effects of Depth of Neuromuscular Blockade and Insufflation Pressure on Surgical ConditionsEUCTR2012-001886-33-ATMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.120
Active, not recruiting
Not Applicable
Effects of Depth of Neuromuscular Blockade and Insufflation Pressure on Surgical ConditionsPatients undergoing elective in-patient laparoscopic cholecystectomy procedures under general anesthesia with neuromuscular relaxation and active reversal of neuromuscular blockadeMedDRA version: 16.1Level: LLTClassification code 10018061Term: General anesthesiaSystem Organ Class: 100000004865EUCTR2012-001886-33-DEMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.120